Triflusal
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA) .
Product Specifications
CAS Number
322-79-2
Product Name Alternative
Triflusal, Disgren, Grendis, Aflen, Triflux
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 50 mg/mL (201.48 mM) ; DMSO: 50 mg/mL (201.48 mM)
Smiles
O=C (O) C1=CC=C (C (F) (F) F) C=C1OC (C) =O
Molecular Formula
C10H7F3O4
Molecular Weight
248.16
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-acetyloxy-4- (trifluoromethyl) benzoic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
051727-01 10 µg
Fasciculation And Elongation Protein Zeta 1 (FEz1), Recombinant, Human, His-Tag, GST-Tag
Sign In for Pricing
View Details 051727-02 50 µg
Fasciculation And Elongation Protein Zeta 1 (FEz1), Recombinant, Human, His-Tag, GST-Tag
Sign In for Pricing
View Details 051727-03 100 µg
Fasciculation And Elongation Protein Zeta 1 (FEz1), Recombinant, Human, His-Tag, GST-Tag
Sign In for Pricing
View Details 051727-04 200 µg
Fasciculation And Elongation Protein Zeta 1 (FEz1), Recombinant, Human, His-Tag, GST-Tag
Sign In for Pricing
View Details